PDS introduces NeuroPET scanner

PhotoDetection Systems (PDS) introduced its NeuroPET scanner to the molecular imaging community at the recent 2009 SNM annual meeting in Toronto.

NeuroPET's wavelength-shifting fiber technology enables high-sensitivity and superior spatial resolution. Its compact/portable design requires no special site preparation, according to the Boxboro, Mass.-based company.

PDS said its scanner uses low doses of 18F and 11C tracers to image metabolism, amyloid and dopaminergic binding in neurological diseases. The tracers are known to be helpful in imaging challenging and costly diseases, such as Alzheimer's, neuro-oncology, epilepsy, Parkinson's and neuro-psychiatric disorders.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.